Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cell Count × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Gastrointestinal 3 Plasma cell 2 Gynecologic 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Myeloid 1 Lymphoid 1 Head & Neck 1 CNS 1

Conditions

Interventions

pembrolizumab 82 Paclitaxel 71 Carboplatin 66 Gemcitabine 65 Nivolumab 49 Docetaxel 47 Cisplatin 47 Bevacizumab 44 Magnetic Resonance Spectroscopy 37 Fluorouracil 37 Capecitabine 37 Irinotecan 32 Radiotherapy 31 Oxaliplatin 31 Pemetrexed 30 Erlotinib Hydrochloride 30 Biopsy 30 Standard of Care 27 atezolizumab 26 Trastuzumab 26 Specimen Handling 25 Leucovorin 25 Sorafenib 24 Everolimus 24 Radiosurgery 22 Ipilimumab 22 Cyclophosphamide 22 Cetuximab 22 Surveys and Questionnaires 21 Blood Specimen Collection 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05887882 2026-03-16

PNOC028

University of California, San Francisco

Phase 1 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡